Example: tourism industry
Neurology NOTCH2NLC
I.V. Brum and G.D. Silva Video Disputes & Debates: Editors’ Choice 88 Editors’ Note: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age A. Ganesh and S. Galetta 88 Reader Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age S.R. Brenner 89 Author Response: Mediterranean Diet ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Practice guideline summary: Sudden unexpected death in ...
n.neurology.orgpractice guideline broadly follows the process delin-eated in the 2004 American Academy of Neurology (AAN) guideline development process manual,1 with the exception of the processes for formulating conclusions and recommendations, which follow the processes explained in the 2011 AAN guideline
Practice guideline update recommendations summary ...
n.neurology.orgSPECIAL ARTICLE Practice guideline update recommendations summary: Disorders of consciousness Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the
Rating neurologic impairment in multiple sclerosis: An ...
n.neurology.orgScale (DSS) that had steps from 0 (normal) to 10 (death due to MS). A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 . . .
Alemtuzumab CARE-MS II 5-year follow-up
n.neurology.orgconfirmed disability worsening (CDW; $1-point Expanded Disability Status Scale [EDSS] score increase [$1.5 if baseline EDSS 5 0]), 6-month confirmed disability improvement (CDI; $1-point ... The Expanded Disability Status Scale (EDSS) was assessed by raters blinded throughout the exten-
Decisions With Patients and Families Regarding Aducanumab ...
n.neurology.orgNov 17, 2021 · The American Academy of Neurology aims to support clinicians, patients and families in navigating these challenging decisions. In this position statement, we examine specific ethical considerations bearing on use of aducanumab based on a widely-accepted framework of principles in biomedical ethics,9 and offer recommendations for informed consent.
International Consensus Guidance for Management of ...
n.neurology.orgJan 19, 2021 · Iodinated radiologic contrast agents Older reports document increased MG weakness, but modern contrast agents appear safer. Use cautiously and observe for worsening. Macrolide antibiotics (e.g., erythromycin, azithromycin, and clarithromycin) Commonlyprescribed antibiotics forgram-positivebacterialinfections. May worsen MG. Use cautiously, if ...
Neurology PRRT2
n.neurology.org31 Oral and Topical Treatment of Painful Diabetic Polyneuropathy:PracticeGuidelineUpdateSummary: Report of the AAN Guideline Subcommittee R.Price,D. Smith,G. Franklin ...
SPECIAL ARTICLE LEVEL OF RECOMMENDATION Practice …
n.neurology.org20 participants, and (4) treatment was compared with placebo. The authors found 2,482 abstracts relevant to acute or pre-ventive therapy for pediatric migraine. The authors reviewed 313 full-text articles and identified 10 new studies of acute therapy to be included in the guideline. Of the 10 acute ...
Oral and Topical Treatment of Painful Diabetic ...
n.neurology.orgTo update the 2011 American Academy of Neurology (AAN) guideline on the treatment of painful diabetic neuropathy (PDN) with a focus on topical and oral medications and medical class effects. Methods The authors systematically searched the literature from January 2008 to …
Decisions With Patients and Families Regarding Aducanumab ...
n.neurology.orgpatient and system costs of this highly expensive medication. Considering charges for infusion services, repeated imaging, and medical management (in rare cases including hospitali-zation for severe symptoms), treatment costs may exceed $100,000 per patient per year, of which Medicare generally covers 80%. Ten percent of Medicare beneficiaries ...